Celia Tam
Dr. Tam is the Managing Director of the Human Neurobehavioral Core Service (HNBCS) / Neurodevelopmental Disorders Phenotyping Program (NDPP) at Boston Children’s Hospital. She is a licensed clinical psychologist with over 15 years of experience in neuropsychological and phenotypic characterization of individuals with neurodevelopmental disorders, including ASD and other developmental disabilities, as well as in behavioral and family-based interventions. Her research has focused on translational and interventional clinical research of various complex medical and rare genetic conditions associated with developmental disability. She has worked on studies ranging from natural history studies to clinical intervention trials to consult around battery and research design as well as to conduct appropriate neurobehavioral assessments.
Raymond Belanger Deloge
Mr. Belanger Deloge is a board certified and licensed genetic counselor. He completed his genetic counseling training at Baylor College of Medicine in Houston, TX. As a Genetic Counselor with the TNC, he specializes in translational research for rare, genetic, neurodevelopmental disorders and facilitating partnerships between the TNC and Patient Advocacy Groups.
Gabriela Davila Mejia
Gabriela Davila Mejia is from Bogota, Colombia, where she earned her B.S. in Psychology with a minor in Mathematics from the University of the Andes. She subsequently completed her M.A. in Psychology at Boston University.
Gabriela joined the Labs of Cognitive Neuroscience as a Research Assistant in 2022, and then transitioned to her current position as Computational Health Informatics Data Manager II in 2023. She is passionate about characterizing and understanding neurodevelopmental disorders, with the goal of impacting diagnostic accuracy as well as intervention design. She is motivated by the importance of effective data management practices to ensure the integrity and reliability of research findings. In her free time, Gabriela enjoys handcrafting, baking, and spending time outdoors.
Zoë Frazier
Ms. Zoë Frazier is a Board-certified and licensed Genetic Counselor at Boston Children’s Hospital. She received her Master in Genetic Counseling from Boston University School of Medicine where her training focused on neurogenetics and rare disease research. She has provided counseling to patients and families diagnosed with autism spectrum disorder and related neurodevelopmental disorders (NDDs) in the BCH Neurogenetics clinic. Additionally, she serves patients diagnosed with rare neurodevelopmental genetic conditions, such as Kleefstra syndrome and Tuberous Sclerosis Complex. Ms. Frazier has managed numerous research protocols within BCH’s Rosamund Stone Zander and Hansjoerg Wyss Translational Neuroscience Center. She has extensive experience in developing and implementing longitudinal natural history studies for rare genetic NDDs. She has worked closely with patient advocacy groups to spearhead the development of multiple NDD research initiatives.
Brian Winklosky
Brian Winklosky is thrilled to be part of the ARIA IMPACT Network as a Senior Clinical Research Program Manager, bringing nearly 30 years of experience in developing and supporting multi-site research initiatives focused on neurodevelopmental disorders. Before joining the Boston Children’s Hospital IMPACT Clinical Coordinating Center team, Brian spent 20 years at Massachusetts General Hospital, where he developed and managed a research portfolio of collaborative, interdisciplinary networks aimed at improving clinical care and quality of life for children with autism and their families.
Brian values strong leadership and clear communication, and has a long history in enhancing research infrastructures and fostering collaborative partnerships. Brian is dedicated to advancing clinical research and improving healthcare outcomes through his commitment to excellence and innovation in the field.
Shannon Gampala-Sagar
Shannon Gampala-Sagar earned her Master of Public Health in Epidemiology and Biostatistics from Boston University School of Public Health in 2023 and her Bachelor of Science in Biology, with a minor in Cognitive Science, from the University of Massachusetts Boston in 2017. With over eight years of experience in clinical research and data management, Shannon has led and contributed to large-scale genetics studies at Boston Children’s Hospital and Brigham and Women’s Hospital. Her research interests include cognitive science, neurobiology, neurodevelopmental and neurodegenerative disorders. Shannon currently works with Dr. Alex Cohen on ARIA within the Clinical Coordinating Center (CCC) as the Assistant Data Coordination Director. In her free time, she enjoys spending time with her family, exploring new cafés with friends and traveling.
Susan Faja
Dr. Susan Faja is an Associate Professor of Pediatrics at Harvard Medical School and a Scientist at Boston Children’s Hospital. As a licensed clinical psychologist with expertise in neuroscience, Dr. Faja employs interdisciplinary methods to improve the lives of autistic people. Her research focuses on understanding social and cognitive functioning, evaluating novel interventions and assessment tools, and investigating individual differences in brain development and intervention response. She has leadership roles on several projects to better understand how biomarkers and lab-based tasks could be used to determine how interventions work and who would be most likely to benefit from them.
Anna Cronin
Anna Cronin is a Clinical Research Specialist at Boston Children’s Hospital in the Rosamund Stone Zander and Hansjoerg Wyss Translational Neuroscience Center. Ms. Cronin received her BS and Master of Public Health focusing on Health Policy and Management at the University of Massachusetts Amherst. In her position, she works with studies relating to multiple conditions that span from natural history studies to gene therapy clinical trials.
Mustafa Sahin
Mustafa Sahin is a pediatric neurologist and developmental neurobiologist at Boston Children’s Hospital and the Bronson Crothers Professor of Neurology at Harvard Medical School. He received his ScB from Brown University and his MD and PhD from Yale School of Medicine. He completed a pediatrics residency at the Children’s Hospital of Philadelphia and a child neurology residency at Boston Children’s Hospital. At Boston Children’s, Dr. Sahin is Director the Rosamund Stone Zander Hansjoerg Wyss Translational Neuroscience Center. He is the co-principal investigator of the Intellectual and Developmental Disabilities Research Center. He directs a national consortium to study biomarkers and the comparative pathobiology of four genetic disorders (TSC, PHTS, SYNGAP1-ID, Phelan-McDermid syndrome), all associated with autism and intellectual disability. His research spans the basic, translational, and clinical spectrum, using stem-cell-derived human neurons, animal models, and patients with rare neurogenetic conditions. He was elected to the National Academy of Medicine in 2023. In 2024, he became Chair of the Department of Neurology at Boston Children’s Hospital.
Maya Chopra
Dr. Maya Chopra, MBBS, FRACP, is a Clinical Geneticist with expertise in the delineation of rare neurodevelopmental syndromes, clinical trial readiness programs for such conditions, and in the evaluation of the mechanistic underpinnings to inform therapeutic approaches. She obtained her medical qualifications from the University of New South Wales in in 2000, and her speciality qualifications from the Royal Australasian College of Physicians and the Human Genetics Society of Australasia in 2010. Dr. Chopra has experience in practicing Clinical Genetics in a range of healthcare systems and cultural settings, having held positions at Royal Prince Alfred Hospital (Sydney, Australia), Shanghai First Maternity and Infant Hospital (Shanghai, China), and The Imagine Institute for Genetic Disease (Paris, France).
Currently, she is appointed at Boston Children’s Hospital, serving as Director of Translational Genomic Medicine at the Translational Neuroscience Center; Medical Co-Director, Neurogenetics and Neurodevelopment; and Attending Physician, Division of Genetics & Genomics, and Assistant Professor of Neurology at Harvard Medical School. Dr. Chopra serves as one of the Chairs of the ClinGen Intellectual Disability/Autism Gene Curation Expert Panel. She is the Principal Investigator of an internationally recruiting longitudinal natural history study of Chopra-Amiel-Gordon syndrome (CAGS) and Medical Director of the multidisciplinary CAGS Clinic and ReNU Syndrome Clinic.